1011.1000 -2.30 (-0.23%)
NSE May 28, 2025 15:31 PM
Volume: 104.4K
 

1011.10
-0.23%
ICICI Securities Limited
Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.
Thyrocare Technologies Ltd. is trading above all available SMAs
More from Thyrocare Technologies Ltd.
Recommended